← Back to Clinical Trials
Recruiting NCT04685746

NCT04685746 BALANCED GROWTH: The Involvement of the Vestibular System in a Child's Cognitive and Motor Development

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT04685746
Status Recruiting
Phase
Sponsor University Ghent
Condition Vestibular Disorder
Study Type OBSERVATIONAL
Enrollment 250 participants
Start Date 2019-07-29
Primary Completion 2028-10-31

Trial Parameters

Condition Vestibular Disorder
Sponsor University Ghent
Study Type OBSERVATIONAL
Phase N/A
Enrollment 250
Sex ALL
Min Age 6 Years
Max Age 13 Years
Start Date 2019-07-29
Completion 2028-10-31
Interventions
Balanced Growth Protocol

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

When a vestibular dysfunction occurs at birth or in early stages of life, one might expect that this may have an enormous impact on a child's development. It is known that a severe congenital or early acquired vestibular deficit in children results in delayed psychomotor milestones. Later in life, children with a vestibular dysfunction may have difficulties with several balance tasks and additional cognitive, motor and/or psychosocial performances. While a few authors have suggested that there is indeed an influence of a vestibular dysfunction upon these different developmental domains (cognitive, motor, educational and psychosocial development), which can be supported by findings in clinical practice as well, literature concerning this topic remains fairly limited. On the other hand, several studies have shown that children with known difficulties in motor and/or cognitive functions have more difficulties in vestibular performances in comparison with their unaffected peers. Although more frequently discussed, the literature on this population is rather scarce too. Therefore, the current project aims to investigate the relationship with and the involvement of the vestibular system in the motor and cognitive development of school-aged children.

Eligibility Criteria

For typically developing children Exclusion Criteria: * Having a (permanent) hearing loss * Having a (permanent) vestibular loss * Having a motor dysfunction * IQ \< 70 For vestibular-impaired children Inclusion Criteria: * Recently (\< 6 months) tested at the Ghent University Hospital * Diagnosed with a vestibular impairment (= alteration on at least one of the vestibular function tests: caloric, rotatory chair, vHIT, cVEMP and/or oVEMP test) For neurodevelopmental group Inclusion Criteria: • Diagnosed by a (neuro)psychiatric team with Autism Spectrum Disorder, Attention deficit/Hyperactivitiy Disorder and/or Developmental Coordination Disorder

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology